Tumor necrosis factor and alcoholic liver disease

Alcoholism: Clinical and Experimental Research

Volumn 22, Issue 5 SUPPL., 1998, Pages

  McClain, Craig J ^a   Barve, Shirish ^a   Barve, Swati ^a   Deaciuc, Ion ^a   Hill, Daniell B ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Alcoholic Hepatitis; Cytokines; Liver Injury; Nuclear Factor B; Tumor Necrosis Factor

Indexed keywords

PREDNISONE; PROSTAGLANDIN DERIVATIVE; TUMOR NECROSIS FACTOR;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; CONFERENCE PAPER; CORTICOSTEROID THERAPY; HUMAN; LIVER TOXICITY; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALIA;

EID: 0031677771     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1998.tb04011.x     Document Type: Conference Paper

References (43)

1. Hill D, Shedlofsky S, McClain C, Diehl AM, Tsukamoto H: Cytokines and liver disease, in Remick DG and Friedland JS (eds): Cytokines in Health and Disease, vol 27, ed 2. New York, Marcel Dekker, Inc., 1997, pp 401-425
2. Tracey KJ: Tumor necrosis factor, in Remick DG and Friedland JS (eds): Cytokines in Health and Disease, vol 27, ed 2. New York, Marcel Dekker, Inc., 1997, pp 223-239
3. Carswell EA, Old IJ, Kassel RL, Green S, Fiore N, Williamson B: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666-3670, 1975
4. Buetler B, Greenwald D, Hulmes JD, et al: Identify of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature 316:522-554, 1985
5. Hishinuma I, Nagakawa J, Hirota K, et al: Tumor necrosis factor-α in galactosamine-induced hepatitis. Hepatology 12:1187-1191, 1990
6. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Stricter RM, Campbell DA, Jr: Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 85:1936-1943, 1990
7. Mizoguchi Y, Tsutsui H, Miyajima K, et al: The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model. Hepatology 7:1184-1188, 1987
8. Smith S, Calzetta A, Bankowski J, Kenworthy-Bott L, Terminelli C: Lipopolysaccharide-induced cytokine production and mortality in mice treated with corynebacterium parvum. J Leukoc Biol 54:23-29, 1993
9. Czaja MJ, Xu J, Alt E: Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology 108:1849-1854, 1995
10. Blazka ME, Wilmer JL, Holladay SD, Wilson RE, Luter MI: Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 133:43-52, 1995
11. Laskin D, Gardner C, Price V, Jollow D: Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 21:1045-1050, 1995
12. Galanos C, Freudenberg M, Reuter W: Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 76:5939, 1979
13. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A: Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 146:1220-1234, 1995
14. Hill DB, Schmidt J, Shedlofsky SI, Cohen DA, McClain CJ: In vitro tumor necrosis factor cytotoxicity in Hep G2 liver cells. Hepatology 21: 1114-1119, 1995
15. Bhagwandeen SB, Apte M, Manwarring L: Endotoxin induced hepatic necrosis in rats on an alcohol diet. J Pathol 152:47-53, 1987
16. Honchel R, Ray MB, Marsano L, et al: Tumor necrosis factor in alcohol enhanced endotoxin liver injury. Alcohol Clin Exp Res 16:665-669, 1992
17. Hansen J, Cherwitz DL, Allen JI: The role of tumor necrosis factor-alpha in acute endotoxin-induced hepatotoxicity in ethanol-fed rats. Hepatology 20:461-474, 1994
18. Nanji AA, Zhao S, Sadrzadeh SM, Waxman DJ: Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology 19:1483-1487, 1994
19. Nanji A, Khettry U, Sadrzadeh S: Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver disease. Proc Soc Exp Biol Med 205:243-247, 1994
20. Nanji AA, Zhao S, Khwaja S, Sadrzadeh SMH, Waxman DJ: Cimetidine prevents alcoholic liver injury in the intragastric feeding rat model. J Pharmacol Exp Ther 269:832-837, 1994
21. Adachi Y, Moore L, Bradford B, Gao W, Thurman R: Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108:218-224, 1995
22. Adachi Y, Bradford B, Gao W, Bojes H, Thurman R: Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Gastroenterology 20:453-460, 1994
23. Iimuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG: Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26:1530-1537, 1997
24. McClain CJ, Cohen DA: Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9:349-351, 1989
25. Bird GL, Sheron N, Goka AK, Alexander GJ, Williams RS: Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 112:917-920, 1990
26. Felver ME, Mezey E, McGuire M, et al: Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 14:255-259, 1990
27. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI: Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13:267-276, 1991
28. Hill DB, Marsano LS, McClain CJ: Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology 18:576-580, 1993
29. Sheron N, Bird G, Koskinas J, et al: Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 18:41-46, 1993
30. Imperiale TF, McCullough AJ: Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. Ann Intern Med 113:299-307, 1990
31. Sinclair SB, Greig PD, Blendis LM, et al: Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report. J Clin Invest 84:1063-1069, 1989
32. Han J, Thompson P, Beutler B: Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 172:391-394, 1990
33. Widomski DL, Walsh RE, Baron DA, et al: Effects of the prostaglandin analogue misoprostol on inflammatory mediator release by human monocytes. Agents and Actions 34:30-31, 1991
34. Nerad JL, Griffiths JK, Van der Meer JWM, et al: A simple rapid method for studying cytokine production by endotoxin-stimulated leukocytes, in The Physiological and Pathological Effects of Cytokines. New York, Wiley-Liss, 1990, pp 19-24
35. Leist M, Gantner F, Bohlinger I, et al: Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J Immunol 153:1778-1788, 1994
36. Perera CS, St. Clair DK, McClain CJ: Differential regulation of manganese Superoxide dismutase activity by alcohol and TNF in human hepatoma cells. Arch Biochem Biophys 323:471-476, 1995
37. Opipari AW, Hu HM, Yabkowitz R, Dixit VM: The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 267:12424-12427, 1992
38. 1-acid glycoprotein against tumor necrosis factor-induced lethality. J Exp Med 180:1571-1575, 1994
39. Billiar TR, Harbrecht BG: Resolving the nitric oxide paradox in acute tissue damage. Gastroenterology 113:1405-1407, 1997
40. Baichwal VR, Baeuerle PA: Apoptosis: Activate NF-κB or die? Curr Biol 7:R94-R96, 1997
41. Lander HM: An essential role for free radicals and derived species in signal transduction. FASEB J 11:118-124, 1997
42. Sen CK, Packer L: Antioxidant and redox regulation of gene transcription. FASEB J 10:709-720, 1996
43. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D: Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167-170, 1995